NEW YORK (GenomeWeb News) – The National Cancer Institute has issued a new grant program that will support population-based studies aimed at creating understanding of how epigenetics may be used to study the development of cancer.
The program, "Epigenetic Approaches in Cancer Epidemiology," is funded through R01 grants that may vary in size and duration depending on the project, and R21 grants of up to $275,000 over two years or up to $200,000 per year.
NCI is interested in funding studies that determine the roles of physical, chemical, and infectious agents as well as behavioral factors on the types and levels of DNA methylation, histone modifications, and miRNA changes in human populations of different races and ethnicities.
The institute also will support research into the roles epigenetic changes may play in the risk of cancer in human populations, and studies that seek to identify genetic, environmental, and host susceptibility factors that modify the risk of cancer associated with different races and ethnic groups.